Literature DB >> 11888506

Dynamics of reverse cholesterol transport: protection against atherosclerosis.

Dmitri Sviridov1, Paul Nestel.   

Abstract

This review considers the antiatherogenic function of high density lipoprotein (HDL) from the point of view of its dynamics within the sequential steps of reverse cholesterol transport (RCT). It is postulated that the efficiency of cholesterol flux through the RCT pathways is clinically more relevant than the HDL cholesterol concentration. The particular role of pre-beta(1)-HDL is reviewed drawing attention to the relationship between its concentration and the flux of cholesterol through the RCT system.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11888506     DOI： 10.1016/s0021-9150(01)00677-3

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


  29 in total

Review 1.  The emergence of sedentary behaviour physiology and its effects on the cardiometabolic profile in young and older adults.

Authors:  D J Ryan; G K Stebbings; G L Onambele
Journal:  Age (Dordr)       Date:  2015-08-28

Review 2.  Metabolism of high density lipoproteins in liver cancer.

Authors:  Jing-Ting Jiang; Ning Xu; Chang-Ping Wu
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

Review 3.  Therapeutic interventions to enhance apolipoprotein A-I-mediated cardioprotection.

Authors:  Michael J Haas; Arshag D Mooradian
Journal:  Drugs       Date:  2010-05-07       Impact factor: 9.546

4.  Modified high-density lipoprotein modulates aldosterone release through scavenger receptors via extra cellular signal-regulated kinase and Janus kinase-dependent pathways.

Authors:  Sarama Saha; Juergen Graessler; Peter E H Schwarz; Claudia Goettsch; Stefan R Bornstein; Steffi Kopprasch
Journal:  Mol Cell Biochem       Date:  2012-03-01       Impact factor: 3.396

Review 5.  Cdc42 - A tryst between host cholesterol metabolism and infection.

Authors:  Dmitri Sviridov; Nigora Mukhamedova
Journal:  Small GTPases       Date:  2016-08-31

6.  Combined effects of a high-fat diet and chronic valproic acid treatment on hepatic steatosis and hepatotoxicity in rats.

Authors:  Li-fang Zhang; Ling-sheng Liu; Xiao-man Chu; Hao Xie; Li-juan Cao; Cen Guo; Ji-ye A; Bei Cao; Meng-jie Li; Guang-ji Wang; Hai-ping Hao
Journal:  Acta Pharmacol Sin       Date:  2014-01-20       Impact factor: 6.150

7.  Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations.

Authors:  Adriaan G Holleboom; Georgios Daniil; Xiaoming Fu; Renliang Zhang; G Kees Hovingh; Alinda W Schimmel; John J P Kastelein; Erik S G Stroes; Joseph L Witztum; Barbara A Hutten; Sotirios Tsimikas; Stanley L Hazen; Angeliki Chroni; Jan Albert Kuivenhoven
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-27       Impact factor: 8.311

Review 8.  Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.

Authors:  Robert S Rosenson; H Bryan Brewer; W Sean Davidson; Zahi A Fayad; Valentin Fuster; James Goldstein; Marc Hellerstein; Xian-Cheng Jiang; Michael C Phillips; Daniel J Rader; Alan T Remaley; George H Rothblat; Alan R Tall; Laurent Yvan-Charvet
Journal:  Circulation       Date:  2012-04-17       Impact factor: 29.690

9.  Human immunodeficiency virus protease inhibitor ritonavir inhibits cholesterol efflux from human macrophage-derived foam cells.

Authors:  Xinwen Wang; Hong Mu; Hong Chai; Dan Liao; Qizhi Yao; Changyi Chen
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

10.  HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner.

Authors:  Ming Gong; Melinda Wilson; Thomas Kelly; Wen Su; James Dressman; Jeanie Kincer; Sergey V Matveev; Ling Guo; Theresa Guerin; Xiang-An Li; Weifei Zhu; Annette Uittenbogaard; Eric J Smart
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.